ARKG | ARK Genomic Revolution ETFAMEXETF golden cross and death cross projections, cross tests and history

$49.51
+$1.22 (+2.53%)

ARK Genomic Revolution ETF (ARKG) is an AMEX-listed ETF that Cruxta has tracked for 50/200 crosses since 2018.

The 50 SMA has sat above the 200 on the daily since May 2026, with no cross projected inside the 30 bars Cruxta tracks. On both the daily and the 4-hour, price sits between the 50 and the 200; on the weekly it is above both.

Timeframe summary

Daily as of 3 Nov 16:00 ET

Price
between the two $49.51 vs 50 $49.93 / 200 $37.52
Projection
No cross projected
Test
No active test
Last cross
Golden cross 29 May 2026 ยท projected 13 bars out

Weekly as of 30 Oct 16:00 ET

Price
above both $51.40 vs 50 $36.08 / 200 $29.55
Projection
No cross projected
Test
No active test
Last cross
Golden cross week of 1 Jun 2026 ยท projected 22 bars out

4-hour as of 3 Nov 13:30 ET

Price
between the two $50.07 vs 50 $50.67 / 200 $45.32
Projection
No cross projected
Test
No active test
Last cross
Golden cross 7 May 2026 bar 2 ยท projected 15 bars out ยท tested 3 bars

Cross history

31
crosses on record since 2018
16 golden15 death
Full cross history โ†’
CrossedDirectionTimeframeProjectedCross test
week of 1 Jun 2026Golden moderateweekly22 bars outNot tested
29 May 2026Golden moderatedaily13 bars outNot tested
7 May 2026Golden4-hour15 bars out3 bar cross test
13 Apr 2026Death steepdaily30 bars out2 bar cross test
24 Feb 2026Death4-hour30 bars out4 bar cross test

About ARKG

ExchangeAMEX
InstrumentETF
Median $ volume, 60 d$208M
4-hour coverageYes, since Oct 2025
History on recordSince 2018

Cruxta · 50/200 moving-average crosses on US equities. Recorded crosses are observations. Projected crosses are projections, not advice.